Symbols / MENS Stock $1.72 -4.97% Jyong Biotech Ltd.
MENS (Stock) Chart
Stock Fundamentals
|
|
|
|
|
|
About
Official websiteJyong Biotech Ltd., a science-driven biotechnology company, develops and commercializes plant-derived drugs for the treatment of urinary system diseases in the United States, the European Union, and Asia. It develops MCS-2 for the treatment of benign prostate hyperplasia/lower urinary tract symptoms; PCP for treating prostate cancer; and interstitial cystitis (IC) for the treatment of IC/bladder pain syndrome. The company was founded in 2002 and is headquartered in New Taipei City, Taiwan.
Ratings
Current target
$1.72
Low
—
High
—
Mean
—
- This week the stock market will make boys into MENs! - Moomoo Mon, 08 Jun 2026 05
- JYONG BIOTECH LTD (MENS) Stock Chart - ChartMill Fri, 05 Jun 2026 07
- Luke Stock Earns Big Ten Men's Golfer of the Week Award - USC Athletics hu, 02 Apr 2026 07
- Taking Stock 2026: How Arizona swimming and diving is looking under Ben Loorz - Arizona Desert Swarm Fri, 05 Jun 2026 13
- Pac-12 Conference and The Big West Announce Collaborative Men’s Soccer Partnership to Strengthen Opportunities in the West - pac-12.com Mon, 30 Mar 2026 07
- Men's Basketball Adds Josh Dixon to 2026-27 Roster - Georgia Southern University Athletics Fri, 17 Apr 2026 07
- Men's Golf Selected for 15th Straight NCAA Regional - soonersports.com Wed, 06 May 2026 07
- 12M Americans have BPH; one biotech is testing a plant-based option - Stock Titan Fri, 29 May 2026 07
- Men’s Wearhouse owner aims to rejoin the stock market - Retail Dive Wed, 22 Apr 2026 07
- Jyong Biotech (NASDAQ:MENS) Stock Price Down 19.3% - Here's What Happened - MarketBeat ue, 16 Dec 2025 08
- Jyong Biotech plunges 49% after InvestingPro’s overvalued warning By Investing.com - Investing.com ue, 18 Nov 2025 08
- After the recent decline, Jyong Biotech Ltd. (NASDAQ:MENS) CEO Fu-Feng Kuo's holdings have lost 33% of their value - simplywall.st Mon, 29 Dec 2025 08
- 2026 NBA draft stock watch: Which NCAA prospects are rising? - ESPN ue, 24 Mar 2026 07
- Rice Men's Tennis Announces 2026 Spring Schedule - Rice University Athletics ue, 09 Dec 2025 08
- 2026 Genesis Collegiate Showcase Canceled Due To Weather - University of Washington Athletics Mon, 16 Feb 2026 08
Insider Transactions
No recent insider transactions.
Financials
Statement View
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Operating Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Operating Expense |
|
2.61
+26.80%
|
2.06
-26.49%
|
2.80
-1.13%
|
2.83
|
| Research And Development |
|
0.81
-12.30%
|
0.93
-13.45%
|
1.07
-16.98%
|
1.29
|
| Selling General And Administration |
|
1.79
+58.90%
|
1.13
-34.59%
|
1.73
+12.15%
|
1.54
|
| Selling And Marketing Expense |
|
0.04
+2.27%
|
0.04
-6.38%
|
0.05
+0.00%
|
0.05
|
| General And Administrative Expense |
|
1.75
+61.20%
|
1.08
-35.38%
|
1.68
+12.53%
|
1.49
|
| Other Gand A |
|
1.75
+61.20%
|
1.08
-35.38%
|
1.68
+12.53%
|
1.49
|
| Total Expenses |
|
2.61
+26.80%
|
2.06
-26.49%
|
2.80
-1.13%
|
2.83
|
| Operating Income |
|
-2.61
-26.80%
|
-2.06
+26.49%
|
-2.80
+1.13%
|
-2.83
|
| Total Operating Income As Reported |
|
-2.61
-26.80%
|
-2.06
+26.49%
|
-2.80
+1.13%
|
-2.83
|
| EBITDA |
|
-2.03
-9.01%
|
-1.86
+46.99%
|
-3.52
+38.77%
|
-5.74
|
| Normalized EBITDA |
|
-2.03
-9.01%
|
-1.86
+46.99%
|
-3.52
+38.77%
|
-5.74
|
| Reconciled Depreciation |
|
0.10
-16.67%
|
0.12
-5.51%
|
0.13
+3.25%
|
0.12
|
| EBIT |
|
-2.13
-7.46%
|
-1.98
+45.54%
|
-3.64
+37.89%
|
-5.87
|
| Net Income |
|
-4.67
-54.72%
|
-3.02
+31.39%
|
-4.40
+33.63%
|
-6.63
|
| Pretax Income |
|
-4.67
-54.72%
|
-3.02
+31.39%
|
-4.40
+33.63%
|
-6.63
|
| Net Non Operating Interest Income Expense |
|
-1.93
-87.65%
|
-1.03
-46.65%
|
-0.70
+7.76%
|
-0.76
|
| Interest Expense Non Operating |
|
2.54
+145.31%
|
1.03
+36.72%
|
0.76
-1.05%
|
0.77
|
| Net Interest Income |
|
-1.93
-87.65%
|
-1.03
-46.65%
|
-0.70
+7.76%
|
-0.76
|
| Interest Expense |
|
2.54
+145.31%
|
1.03
+36.72%
|
0.76
-1.05%
|
0.77
|
| Interest Income Non Operating |
|
0.61
+8614.29%
|
0.01
-87.50%
|
0.06
+1020.00%
|
0.01
|
| Interest Income |
|
0.61
+8614.29%
|
0.01
-87.50%
|
0.06
+1020.00%
|
0.01
|
| Other Income Expense |
|
-0.14
-307.69%
|
0.07
+107.21%
|
-0.90
+70.34%
|
-3.04
|
| Other Non Operating Income Expenses |
|
-0.14
-307.69%
|
0.07
+107.21%
|
-0.90
+70.34%
|
-3.04
|
| Tax Provision |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Tax Rate For Calcs |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-4.67
-54.72%
|
-3.02
+31.39%
|
-4.40
+33.63%
|
-6.63
|
| Net Income From Continuing Operation Net Minority Interest |
|
-4.67
-54.72%
|
-3.02
+31.39%
|
-4.40
+33.63%
|
-6.63
|
| Net Income From Continuing And Discontinued Operation |
|
-4.67
-54.72%
|
-3.02
+31.39%
|
-4.40
+33.63%
|
-6.63
|
| Net Income Continuous Operations |
|
-4.67
-54.72%
|
-3.02
+31.39%
|
-4.40
+33.63%
|
-6.63
|
| Normalized Income |
|
-4.67
-54.72%
|
-3.02
+31.39%
|
-4.40
+33.63%
|
-6.63
|
| Net Income Common Stockholders |
|
-4.67
-54.72%
|
-3.02
+31.39%
|
-4.40
+33.63%
|
-6.63
|
| Diluted EPS |
|
—
|
-0.04
+31.39%
|
-0.06
+33.63%
|
-0.09
|
| Basic EPS |
|
—
|
-0.04
+31.39%
|
-0.06
+33.63%
|
-0.09
|
| Basic Average Shares |
|
—
|
76.03
+0.00%
|
76.03
+0.00%
|
76.03
|
| Diluted Average Shares |
|
—
|
76.03
+0.00%
|
76.03
+0.00%
|
76.03
|
| Diluted NI Availto Com Stockholders |
|
-4.67
-54.72%
|
-3.02
+31.39%
|
-4.40
+33.63%
|
-6.63
|
| Line Item | Trend | 2025-12-31 |
|---|---|---|
| Total Assets |
|
20.78
|
| Current Assets |
|
15.54
|
| Cash Cash Equivalents And Short Term Investments |
|
1.18
|
| Cash And Cash Equivalents |
|
1.18
|
| Cash Equivalents |
|
1.17
|
| Cash Financial |
|
0.00
|
| Other Short Term Investments |
|
—
|
| Receivables |
|
13.51
|
| Loans Receivable |
|
13.51
|
| Restricted Cash |
|
0.00
|
| Other Current Assets |
|
0.85
|
| Total Non Current Assets |
|
5.24
|
| Net PPE |
|
3.15
|
| Gross PPE |
|
4.90
|
| Accumulated Depreciation |
|
-1.75
|
| Properties |
|
0.00
|
| Land And Improvements |
|
0.99
|
| Buildings And Improvements |
|
2.59
|
| Machinery Furniture Equipment |
|
0.14
|
| Construction In Progress |
|
0.14
|
| Other Properties |
|
0.89
|
| Leases |
|
0.15
|
| Non Current Deferred Assets |
|
0.00
|
| Other Non Current Assets |
|
2.08
|
| Total Liabilities Net Minority Interest |
|
45.68
|
| Current Liabilities |
|
34.81
|
| Payables And Accrued Expenses |
|
22.97
|
| Payables |
|
0.07
|
| Accounts Payable |
|
0.00
|
| Current Accrued Expenses |
|
22.90
|
| Current Debt And Capital Lease Obligation |
|
8.36
|
| Current Debt |
|
8.28
|
| Other Current Borrowings |
|
8.28
|
| Current Capital Lease Obligation |
|
0.08
|
| Other Current Liabilities |
|
3.48
|
| Total Non Current Liabilities Net Minority Interest |
|
10.87
|
| Long Term Debt And Capital Lease Obligation |
|
10.19
|
| Long Term Debt |
|
10.16
|
| Long Term Capital Lease Obligation |
|
0.03
|
| Tradeand Other Payables Non Current |
|
0.00
|
| Other Non Current Liabilities |
|
0.06
|
| Stockholders Equity |
|
-24.91
|
| Common Stock Equity |
|
-24.91
|
| Capital Stock |
|
0.00
|
| Common Stock |
|
0.00
|
| Share Issued |
|
76.03
|
| Ordinary Shares Number |
|
74.23
|
| Treasury Shares Number |
|
1.79
|
| Additional Paid In Capital |
|
28.53
|
| Retained Earnings |
|
-37.75
|
| Gains Losses Not Affecting Retained Earnings |
|
0.68
|
| Treasury Stock |
|
16.37
|
| Other Equity Adjustments |
|
0.68
|
| Total Equity Gross Minority Interest |
|
-24.91
|
| Total Capitalization |
|
-14.75
|
| Working Capital |
|
-19.27
|
| Invested Capital |
|
-6.46
|
| Total Debt |
|
18.55
|
| Net Debt |
|
17.27
|
| Capital Lease Obligations |
|
0.11
|
| Net Tangible Assets |
|
-24.91
|
| Tangible Book Value |
|
-24.91
|
| Dueto Related Parties Current |
|
0.07
|
| Dueto Related Parties Non Current |
|
0.63
|
| Interest Payable |
|
0.32
|
| Line Of Credit |
|
—
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-3.04
+16.09%
|
-3.62
-39.33%
|
-2.60
+12.45%
|
-2.97
|
| Cash Flow From Continuing Operating Activities |
|
-3.04
+16.09%
|
-3.62
-39.33%
|
-2.60
+12.45%
|
-2.97
|
| Net Income From Continuing Operations |
|
-4.67
-54.72%
|
-3.02
+31.39%
|
-4.40
+33.63%
|
-6.63
|
| Depreciation Amortization Depletion |
|
0.10
-16.67%
|
0.12
-5.51%
|
0.13
+3.25%
|
0.12
|
| Depreciation |
|
0.10
-16.67%
|
0.12
-5.51%
|
0.13
|
—
|
| Depreciation And Amortization |
|
0.10
-16.67%
|
0.12
-5.51%
|
0.13
+3.25%
|
0.12
|
| Other Non Cash Items |
|
-19.20
-2623.26%
|
0.76
+37.36%
|
0.55
-7.51%
|
0.60
|
| Operating Gains Losses |
|
-0.00
|
—
|
—
|
—
|
| Gain Loss On Investment Securities |
|
-0.00
|
—
|
—
|
—
|
| Change In Working Capital |
|
20.73
+1495.36%
|
-1.49
-232.92%
|
1.12
-61.93%
|
2.94
|
| Change In Prepaid Assets |
|
-0.75
-9262.50%
|
-0.01
-300.00%
|
-0.00
-101.19%
|
0.17
|
| Change In Payables And Accrued Expense |
|
21.58
+12667.46%
|
0.17
-42.52%
|
0.29
+243.41%
|
-0.20
|
| Change In Accrued Expense |
|
21.58
+12744.05%
|
0.17
-43.24%
|
0.30
+267.23%
|
-0.18
|
| Change In Payable |
|
-0.00
-200.00%
|
0.00
+150.00%
|
-0.00
+92.86%
|
-0.03
|
| Change In Account Payable |
|
-0.00
-200.00%
|
0.00
+150.00%
|
-0.00
+92.86%
|
-0.03
|
| Change In Other Current Assets |
|
—
|
—
|
—
|
0.00
|
| Change In Other Current Liabilities |
|
-0.09
+94.35%
|
-1.65
-299.39%
|
0.83
-72.23%
|
2.97
|
| Investing Cash Flow |
|
-13.51
|
0.00
-100.00%
|
0.10
-93.18%
|
1.39
|
| Cash Flow From Continuing Investing Activities |
|
-13.51
|
0.00
-100.00%
|
0.10
-93.18%
|
1.39
|
| Net PPE Purchase And Sale |
|
—
|
—
|
0.00
+100.00%
|
-0.25
|
| Purchase Of PPE |
|
—
|
—
|
0.00
+100.00%
|
-0.25
|
| Capital Expenditure |
|
—
|
—
|
—
|
-0.25
|
| Net Investment Purchase And Sale |
|
0.00
|
0.00
-100.00%
|
0.10
-94.20%
|
1.64
|
| Purchase Of Investment |
|
-16.87
|
0.00
|
0.00
+100.00%
|
-0.29
|
| Sale Of Investment |
|
16.87
|
0.00
-100.00%
|
0.10
-95.08%
|
1.93
|
| Net Other Investing Changes |
|
-13.51
|
—
|
—
|
—
|
| Financing Cash Flow |
|
17.63
+786.08%
|
1.99
-1.87%
|
2.03
-39.15%
|
3.33
|
| Cash Flow From Continuing Financing Activities |
|
17.63
+786.08%
|
1.99
-1.87%
|
2.03
-39.15%
|
3.33
|
| Net Issuance Payments Of Debt |
|
-0.02
-101.09%
|
2.20
-10.92%
|
2.47
-31.48%
|
3.61
|
| Issuance Of Debt |
|
24.47
+109.74%
|
11.67
-1.36%
|
11.83
-3.65%
|
12.28
|
| Repayment Of Debt |
|
-24.50
-158.81%
|
-9.46
-1.17%
|
-9.36
-7.94%
|
-8.67
|
| Long Term Debt Issuance |
|
1.38
-43.30%
|
2.43
+19.79%
|
2.03
+116.22%
|
0.94
|
| Long Term Debt Payments |
|
-1.56
-2097.18%
|
-0.07
+70.78%
|
-0.24
+16.49%
|
-0.29
|
| Net Long Term Debt Issuance |
|
-0.18
-107.81%
|
2.36
+32.14%
|
1.78
+176.01%
|
0.65
|
| Short Term Debt Issuance |
|
23.10
+149.93%
|
9.24
-5.73%
|
9.80
-13.55%
|
11.34
|
| Short Term Debt Payments |
|
-22.94
-144.16%
|
-9.39
-3.08%
|
-9.11
-8.79%
|
-8.38
|
| Net Short Term Debt Issuance |
|
0.16
+204.58%
|
-0.15
-122.17%
|
0.69
-76.71%
|
2.96
|
| Net Common Stock Issuance |
|
17.77
|
0.00
|
0.00
|
—
|
| Net Other Financing Charges |
|
-0.11
+46.48%
|
-0.21
+52.13%
|
-0.45
-61.23%
|
-0.28
|
| Changes In Cash |
|
1.08
+166.40%
|
-1.63
-241.84%
|
-0.48
-127.25%
|
1.75
|
| Effect Of Exchange Rate Changes |
|
-0.01
-14.29%
|
-0.01
+87.04%
|
-0.05
-74.19%
|
-0.03
|
| Beginning Cash Position |
|
0.10
-94.20%
|
1.74
-23.39%
|
2.27
+312.70%
|
0.55
|
| End Cash Position |
|
1.18
+1066.34%
|
0.10
-94.20%
|
1.74
-23.39%
|
2.27
|
| Free Cash Flow |
|
-3.04
+16.09%
|
-3.62
-39.33%
|
-2.60
+19.15%
|
-3.22
|
| Interest Paid Supplemental Data |
|
0.34
+51.12%
|
0.22
+114.42%
|
0.10
-35.80%
|
0.16
|
| Income Tax Paid Supplemental Data |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Common Stock Issuance |
|
17.77
|
0.00
|
0.00
|
—
|
| Issuance Of Capital Stock |
|
17.77
|
0.00
|
0.00
|
—
|
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|